We are live on
!
Find out more
Jasper Therapeutics
JSPR
JSPR
58 hedge funds and large institutions have $13.9M invested in Jasper Therapeutics in 2026 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
340% more call options, than puts
Call options by funds: $110K | Put options by funds: $25K
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
15% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 13
5% more funds holding
Funds holding: 55 → 58 (+3)
12.18% less ownership
Funds ownership: 68.69% → 56.51% (-12%)
61% less capital invested
Capital invested by funds: $35.2M → $13.9M (-$21.3M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
58
Holders Change
+3
Holders Change %
+5.45%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
15
Reduced
13
Closed
9
Calls
$110K
Puts
$25K
Net Calls
+$85K
Net Calls Change
-$297K
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$3.2M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$1.9M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$1.77M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$888K |
| 5 |
Morgan Stanley
New York
|
-$883K |
